Finance

Lists
RGBP:OTCMKTS
Regen BioPharma Inc
1,95 USD
0,00%
(0,00) 1D
31-мар., 15:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGBP...
High
2,18 USD
Low
1,95 USD
Mkt. cap
355,12 миң
Avg. vol.
15,04 миң
Volume
3,20 миң
52-wk high
19,80 USD
52-wk low
1,25 USD
EPS
-0,64 USD
Beta
6,38
Shares outstanding
3,37 млн
No. of employees
1
High
2,18 USD
Low
1,95 USD
Mkt. cap
355,12 миң
Avg. vol.
15,04 миң
Volume
3,20 миң
52-wk high
19,80 USD
52-wk low
1,25 USD
EPS
-0,64 USD
Beta
6,38
Shares outstanding
3,37 млн
No. of employees
1
News stories
From web sources and news partners
About Regen BioPharma Inc
CEO-
Employees1
Founded2012
HeadquartersЛа Меса, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
59,37 миң
59,06 миң
59,06 миң
59,06 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11,72 миң
210,00 миң
2,22 миң
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
170,70 миң
400,69 миң
210,56 миң
34,54 миң
Operating expense
182,42 миң
610,69 миң
212,77 миң
34,54 миң
Total operating expenses
182,42 миң
610,69 миң
212,77 миң
34,54 миң
Operating income
-123,06 миң
-551,62 миң
-153,71 миң
24,53 миң
Other non operating income
-349,22 миң
-380,83 миң
1,18 млн
-623,20 миң
EBT including unusual items
-572,47 миң
-967,85 миң
991,93 миң
-637,78 миң
EBT excluding unusual items
-572,47 миң
-967,85 миң
991,93 миң
-637,78 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-572,47 миң
-967,85 миң
991,93 миң
-637,78 миң
Net profit margin
-964,30%
-1 638,62%
1 679,38%
-1 079,80%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-100,20 миң
-35,40 миң
-36,04 миң
-39,11 миң
Net interest expenses
-100,20 миң
-35,40 миң
-36,04 миң
-39,11 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору